Funds holding LEGEND BIOTECH CORP
ISIN US52490G1022 · Cayman Islands · LEI 254900EIUFZTW136H859
- Fund holders
- 134
- Of which ETFs
- 26 108 other funds
- Value held
- 654.4M $ 13.3M SEK · 688.9K €
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| State Street(R) SPDR(R) MSCI ACWI ex-US ETF SPDR INDEX SHARES FUNDS | 7,456 | 134.9K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 7,400 | 133.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Global Equities Account College Retirement Equities Fund | 5,949 | 107.6K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| WisdomTree Emerging Markets ex-State-Owned Enterprises Fund WisdomTree Trust | 5,464 | 98.8K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Guardian Large Cap Fundamental Growth VIP Fund Guardian Variable Products Trust | 5,400 | 97.7K $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series EM Portfolio Voya VARIABLE PORTFOLIOS INC | 4,845 | 87.6K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Total International Ex U.S. Index Master Portfolio Master Investment Portfolio | 4,843 | 87.6K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 4,707 | 89.4K $ | 0.12 % | as of Feb 28, 2026 ↗ |
| ULTRACHINA PROFUND ProFunds | 4,226 | 99.4K $ | 0.44 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF SPDR INDEX SHARES FUNDS | 4,106 | 74.3K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| STATE STREET EMERGING MARKETS EQUITY INDEX FUND STATE STREET INSTITUTIONAL INVESTMENT TRUST | 4,000 | 72.4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 3,888 | 73.9K $ | 0.08 % | as of Feb 28, 2026 ↗ |
| AVIP Fidelity Institutional AM Equity Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 3,454 | 62.5K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Variable Trust | 2,794 | 50.5K $ | 0.47 % | as of Mar 31, 2026 ↗ |
| VIP International Index Portfolio Variable Insurance Products Fund II | 2,793 | 50.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 2,518 | 47.8K $ | 0.17 % | as of Feb 28, 2026 ↗ |
| International Equity Index Trust John Hancock Variable Insurance Trust | 2,500 | 45.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Emerging Markets Equity Fund MORGAN STANLEY PATHWAY FUNDS | 2,342 | 44.5K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| LVIP SSGA Emerging Markets Equity Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,800 | 32.6K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 1,675 | 31.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| MFS Global Alternative Strategy Fund MFS Series Trust XV | 1,379 | 32.4K $ | 0.02 % | as of Apr 30, 2026 ↗ |
| iShares MSCI BIC ETF iShares, Inc. | 1,290 | 24.5K $ | 0.03 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) MSCI Emerging Markets Fossil Fuel Reserves Free ETF SPDR INDEX SHARES FUNDS | 1,096 | 19.8K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| PD Emerging Markets Index Portfolio PACIFIC SELECT FUND | 899 | 16.3K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| State Street Small-Cap Equity V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 809 | 14.6K $ | 0.07 % | as of Mar 31, 2026 ↗ |
| SA Emerging Markets Equity Index Portfolio SUNAMERICA SERIES TRUST | 740 | 17.4K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets Equity Fund American Century ETF Trust | 725 | 13.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Emerging Markets Equity PLUS Portfolio EQ Advisors Trust | 645 | 11.7K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 600 | 10.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Xtrackers MSCI Emerging Markets Hedged Equity ETF DBX ETF Trust | 565 | 10.7K $ | 0.01 % | as of Feb 27, 2026 ↗ |
| Xtrackers MSCI All World ex US Hedged Equity ETF DBX ETF Trust | 539 | 10.2K $ | 0.00 % | as of Feb 27, 2026 ↗ |
| State Street(R) SPDR(R) MSCI Emerging Markets StrategicFactors(SM) ETF SPDR INDEX SHARES FUNDS | 135 | 2.4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 416.3K € | 0.50 % | as of Dec 31, 2025 ↗ | |
| ZENTIUS INVERSIONES SICAV, S.A. BANKINTER GESTION DE ACTIVOS, S.A., S.G.I.I.C. | 272.6K € | 0.57 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Harbor Health Care ETF Harbor ETF Trust | 5.13 % | as of Apr 30, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 3.26 % | as of Feb 28, 2026 ↗ |
| Matthews Emerging Markets Discovery Active ETF Matthews International Funds | 2.50 % | as of Mar 31, 2026 ↗ |
| Matthews Emerging Markets Small Companies Fund Matthews International Funds | 2.22 % | as of Mar 31, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 2.14 % | as of Feb 28, 2026 ↗ |
| Matthews Emerging Markets Sustainable Future Active ETF Matthews International Funds | 1.90 % | as of Mar 31, 2026 ↗ |
| Matthews Emerging Markets Sustainable Future Fund Matthews International Funds | 1.81 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.73 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.68 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 1.37 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 129 | -14 | 32,480,248 | +2.8 % |
| 2026Q1 | 143 | -24 | 31,584,203 | -16.8 % |
| 2025Q4 | 167 | -2 | 37,983,456 | +6.3 % |
| 2025Q3 | 169 | -23 | 35,722,306 | -0.9 % |
| 2025Q2 | 192 | -6 | 36,033,849 | +6.5 % |
| 2025Q1 | 198 | -24 | 33,827,698 | -16.3 % |
| 2024Q4 | 222 | +8 | 40,430,810 | +1.6 % |
| 2024Q3 | 214 | -8 | 39,810,424 | +4.8 % |
| 2024Q2 | 222 | +4 | 37,996,959 | +12.0 % |
| 2024Q1 | 218 | -6 | 33,913,250 | -6.4 % |
| 2023Q4 | 224 | 36,227,698 |
Institutional managers
187 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 25,696,740 | 464.9M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 7,687,638 | 139.1M $ | as of Mar 31, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,581,029 | 137.1M $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 5,984,550 | 108.3M $ | as of Mar 31, 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5,763,475 | 104.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,684,543 | 84.7M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 3,886,017 | 70.3M $ | as of Mar 31, 2026 |
| First Beijing Investment Ltd | 2,296,335 | 41.5M $ | as of Mar 31, 2026 |
| Artisan Partners Limited Partnership | 2,254,488 | 40.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,890,396 | 34.2M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 1,576,295 | 28.5M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 1,527,336 | 27.6K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,498,372 | 27.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,464,112 | 26.5M $ | as of Mar 31, 2026 |
| Davern Capital Partners, LP | 1,314,748 | 23.8M $ | as of Mar 31, 2026 |
| Patient Square Capital LP | 990,000 | 17.9M $ | as of Mar 31, 2026 |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 925,920 | 16.7M $ | as of Mar 31, 2026 |
| Hudson Bay Capital Management LP | 876,351 | 15.9M $ | as of Mar 31, 2026 |
| JOHNSON & JOHNSON | 814,586 | 14.7M $ | as of Mar 31, 2026 |
| IvyRock Asset Management (HK) Ltd | 804,000 | 14.5M $ | as of Mar 31, 2026 |
| ArrowMark Colorado Holdings LLC | 727,144 | 13.2M $ | as of Mar 31, 2026 |
| Capital International Investors | 647,850 | 11.7M $ | as of Mar 31, 2026 |
| Triata Capital Ltd | 629,914 | 11.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 603,247 | 10.9M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 574,898 | 10.4M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding LEGEND BIOTECH CORP". https://titelia.com/en/stocks/legend-biotech-corp-US52490G1022